By Chris SimmsNeurons in the brains of mice tell them to stop eating when they’ve had enough food – and since people probably ...

The Food and Drug Administration on Tuesday approved Ozempic to reduce the risk of serious complications in people who have ...

One recent analysis found that, over the course of three years, people taking semaglutide (the compound in Ozempic and the ...

The U.S. Food and Drug Administration (FDA) has officially approved Ozempic to help reduce the risk of serious kidney ...

Few drugs in recent years have shaken up medicine and society at large to the degree that semaglutide and its siblings have. Semaglutide is the active ingredient in diabetes drug Ozempic and ...

Semaglutide and tirzepatide may be linked to ophthalmic complications due to rapid hyperglycemia correction, not drug toxicity. The study involved nine patients, with seven cases of nonarteritic ...

Let's take a closer look at each of these medications. Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient ...

Semaglutide is now approved for T2D patients with CKD, reducing cardiovascular and kidney disease risks. The FLOW phase 3b trial showed significant reductions in adverse kidney and cardiovascular ...

both tirzepatide and semaglutide were declared in shortage by the FDA. During a declared shortage, state-licensed pharmacists and physicians are allowed to compound these medications if they ...